Under-eye dark circles guide: matching treatment to the correct cause
A complete guide to under-eye dark circles — the four distinct etiologies (vascular/hemosiderin, melanin/pigment, structural tear trough hollowing, and lower lid fat prolapse shadowing), why treatments fail when mismatched to the underlying cause, how to identify which etiology dominates with the stretch test and lighting assessment, the evidence for HA tear trough filler (structural), carboxytherapy (vascular), laser and topicals (pigment), and surgery (fat prolapse).
Under-eye dark circles are among the most common aesthetic concerns — and among the most frequently undertreated, overtreated, or incorrectly treated. The reason: dark circles have four distinct etiologies, each requiring a different treatment. Eye cream will not correct a tear trough deficiency; filler will not resolve melanin pigmentation; carboxytherapy will not improve lower lid fat prolapse shadowing. Identifying the dominant cause is the prerequisite to effective treatment. Here is the complete diagnostic and treatment guide.
The four etiologies: identification and treatment
Etiology 1: Vascular / hemosiderin dark circles
What it is: The periorbital skin is the thinnest skin on the face — averaging 0.5 mm at the lower eyelid. The dense vascular network of the orbicularis oculi muscle and the underlying venous plexus shows through this thin skin as a bluish-purple discoloration.
Additionally, microbleeds in the periorbital tissue (from vascular fragility, allergies, eye rubbing) deposit hemosiderin (iron from degraded hemoglobin) — producing brownish-red deposits that accumulate as chronic periorbital discoloration.
Identifying features:
Blue-purple or red-brown hue
Stretch test: Gently stretch the skin under the eye — vascular/hemosiderin circles remain or change only slightly when stretched (the color is in the vascular network, not the skin surface)
Worsens with fatigue, alcohol, allergies (vasodilation increases visible blood pooling)
Most prominent in the morning and in cold environments
Treatments:
Carboxytherapy: CO2 injection triggers the Bohr effect → vasodilation → improved oxygenation of sluggish periorbital blood → reduces the blue-purple appearance of deoxygenated blood pooling. Mehryan et al. (2014, Journal of Cosmetic Dermatology) split-face RCT: significant improvement in dark circle score vs. control. 6–8 sessions, weekly.
Topical vitamin K: Some evidence for reducing periorbital hemosiderin by supporting coagulation-related clearance; modest effect
Retinoids: Increase collagen density in the thin periorbital skin → dermis becomes more opaque → the vascular network shows through less. Modest improvement with consistent use.
Pulsed dye laser (PDL) / IPL: Targets the vascular component; improves the red-blue discoloration from periorbital vasculature. 1–3 sessions.
Etiology 2: Pigment / melanin dark circles
What it is: Increased melanin deposition in the periorbital epidermis and superficial dermis — producing brown discoloration that is distinct from the blue-purple of vascular circles. Common in Fitzpatrick types III–VI (genetic predisposition to periorbital hyperpigmentation); also from post-inflammatory hyperpigmentation from eye rubbing, contact dermatitis to eye products, or sun exposure.
Identifying features:
Brown hue (not blue-purple)
Stretch test: Pigment circles lighten or disappear when the skin is stretched — the pigment is in the epidermis and the stretching reduces its visual density
Does not change significantly with fatigue or time of day
Often extends onto the upper lid and lateral canthus area
Common family history
Treatments:
Topical depigmenting agents: Hydroquinone 2–4% (prescription), kojic acid, azelaic acid, tranexamic acid, niacinamide — applied to the periorbital area (with care); reduce melanin synthesis over 8–12 weeks of consistent use
Sunscreen (periorbital): UV exposure drives melanocyte activity; mineral SPF applied carefully around the eyes prevents further accumulation
Chemical peels (mild): Glycolic acid 30–50% or mandelic acid peels targeting epidermal pigment — applied by an experienced provider with careful eye protection
Q-switched Nd:YAG 1064 nm or 532 nm laser: Photoacoustic disruption of epidermal melanin; appropriate for discrete periorbital pigmentation and hemosiderin deposits. Risk: PIH in darker skin types; requires experienced provider and test treatment
What it is: Not a true dark circle — but the most common cause of the "tired look" associated with periorbital darkness. The tear trough is the groove running from the inner corner of the eye along the orbital rim. As volume is lost with aging (mid-face volume loss, orbital fat descent, and bone resorption of the orbital rim), this groove deepens — casting a shadow that appears as a dark circle.
Identifying features:
The darkness is a shadow, not skin discoloration
Lighting test: In direct overhead lighting, the shadow disappears or significantly lessens — the groove itself causes the dark appearance
Stretch test: No change — stretching the skin does not affect a cast shadow
Worsens progressively with age as volume loss deepens the tear trough
Most prominent in the lateral portion (under-eye hollowing) rather than medial (nasal) — or vice versa depending on anatomy
Treatments:
Hyaluronic acid tear trough filler: The definitive treatment for structural tear trough hollowing. Non-cross-linked or lightly cross-linked HA (Restylane-L, Belotero Balance, Juvederm Volbella) is placed along the orbital rim or directly in the tear trough groove to restore the concavity. The shadow disappears as the hollow is filled. Requires an experienced injector — the periorbital area is high-risk for Tyndall effect, vascular occlusion (angular artery), and nodule formation. See the Tear Trough Filler guide for the complete technique.
Radiesse (CaHA) — deep orbital rim: Used by some experienced injectors for the deep orbital rim (not directly in tear trough); collagen stimulation + volumization
Surgical lower blepharoplasty + fat repositioning: For patients with significant orbital fat descent and dermatochalasis — surgical repositioning of the descended fat repositions the natural volume into the tear trough groove. Longer-lasting than filler; appropriate for moderate-to-severe structural change
Etiology 4: Fat prolapse — lower lid shadowing
What it is: Distinct from tear trough hollowing — this is the lower eyelid fat bags (malar bags). The orbital fat herniation through a weakened orbital septum creates a convex bulge of the lower lid. The shadow below the fat bulge creates the dark appearance.
Identifying features:
The "dark circle" is actually the shadow beneath a visible lower lid swelling
Lower lid is puffy or convex, not hollow
Worsens in the morning (fluid redistribution) and with salt intake
Often familial; present from young adulthood
Treatments:
Surgical lower blepharoplasty: The definitive treatment — excision or repositioning of the herniated orbital fat. The shadow disappears because the fat bulge producing the shadow is removed.
Filler in the adjacent cheek (cheek lift technique): Adding volume below the fat prolapse can reduce the transition and shadow — not removing the fat but camouflaging the shadow. A temporizing measure.
Carboxytherapy: Improves microcirculation and can reduce morning puffiness component; not effective for true fat herniation.
The diagnostic approach: which etiology dominates?
Most patients have more than one contributing etiology. The approach:
Stretch test: Stretch the under-eye skin firmly.
Color persists → vascular/hemosiderin component
Color lightens → pigment component
Shadow persists → structural component
Lighting test: Look in direct overhead light.
Dark circles disappear → shadowing (structural or fat prolapse)
Dark circles persist → vascular or pigment
Hue assessment:
Blue-purple → vascular dominant
Brown → pigment dominant
Gray/dark shadow → structural or fat prolapse dominant
Time-of-day variation:
Worse in the morning → vascular pooling or fat/fluid prolapse